Salvage radiotherapy in patients with prostate cancer and biochemical relapse after radical prostatectomy. Long-term follow-up of a single-center survey

Strahlentherapie und Onkologie

Volumn 190, Issue 8, 2014, Pages 727-731

  Lohm, Gunnar ^a   Lütcke, Jörg ^a   Jamil, Basil ^b   Höcht, Stefan ^c   Neumann, Konrad ^a   Hinkelbein, Wolfgang ^a   Wiegel, Thomas ^d   Bottke, Dirk ^d  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Klinikum Frankfurt/Oder   (Germany)

^c X Care Praxis für Strahlentherapie Saarlouis ^*  (Germany)

^d UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

Biochemical relapse; Prostate cancer; Prostate specific antigen; Radical prostatectomy; Salvage radiotherapy

Indexed keywords

ADULT; AGED; ARTICLE; BIOCHEMICAL COMPOSITION; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; FOLLOW UP; GLEASON SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PROGRESSION FREE SURVIVAL; PROSTATE CANCER; PROSTATECTOMY; SALVAGE THERAPY;

COMBINED MODALITY THERAPY; FOLLOW-UP STUDIES; HUMANS; MALE; NEOPLASM GRADING; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RADIOTHERAPY, ADJUVANT; SALVAGE THERAPY; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 84906940400     PISSN: 01797158     EISSN: 1439099X     Source Type: Journal    
DOI: 10.1007/s00066-014-0612-6     Document Type: Article

References (23)

1. Bolla M, van PH, Tombal B et al (2012) Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911). Lancet 380:2018-2027
2. Bottke D, Bartkowiak D, Schrader M et al (2012) Radiotherapy after radical prostatectomy: immediate or early delayed? Strahlenther Onkol 188:1096-1101
3. Briganti A, Wiegel T, Joniau S (2012) Early salvage radiation therapy does not compromise cancer control in patients with pT3N0 prostate cancer after radical prostatectomy: results of a match-controlled multi-institutional analysis. Eur Urol 62:472-487
4. Budiharto T, Perneel C, Haustermans K et al (2010) A multi-institutional analysis comparing adjuvant and salvage radiation therapy for high-risk prostate cancer patients with undetectable PSA after prostatectomy. Radiother Oncol 97:474-479
5. Cremers RG, van Lin EN, Gerrits WL (2010) Efficacy and tolerance of salvage radiotherapy after radical prostatectomy, with emphasis on high-risk patients suited for adjuvant radiotherapy. Radiother Oncol 97:467-473
6. Goenka A, Magsanoc JM, Pei X (2011) Improved toxicity profile following high-dose postprostatectomy salvage radiation therapy with intensity-modulated radiation therapy. Eur Urol 60:1142-1148
7. Heidenreich A, Bastian PJ, Bellmunt J (2014) EAU guidelines on prostate cancer. Part II: treatment of advanced, relapsing, and castration-resistant prostate cancer. Eur Urol 65:467-479
8. King CR (2012) Adjuvant versus salvage radiotherapy after prostatectomy: the apple versus the orange. Int J Radiat Oncol Biol Phys 82:1045-1046
9. King CR (2012) The timing of salvage radiotherapy after radical prostatectomy: a systematic review. Int J Radiat Oncol Biol Phys 84:104-111
10. Neuhof D, Hentschel T, Bischof M (2007) Long-term results and predictive factors of three-dimensional conformal salvage radiotherapy for biochemical relapse after prostatectomy. Int J Radiat Oncol Biol Phys 67:1411-1417 (Pubitemid 46467172)
11. Ohri N, Dicker AP, Trabulski EJ et al (2012) Can early implementation of salvage radiotherapy for prostate cancer improve the therapeutic ratio? A systematic review and regression meta-analysis with radiobiological modelling. Eur J Cancer 48:837-844
12. Pisansky TM, Kozelsky TF, Myers RP (2000) Radiotherapy for isolated serum prostate specific antigen elevation after prostatectomy for prostate cancer. J Urol 163:845-850 (Pubitemid 30091629)
13. Siegmann A, Bottke D, Faehndrich J et al (2011) Dose escalation for patients with decreasing PSA during radiotherapy for elevated PSA after radical prostatectomy improves biochemical progression-free survival: results of a retrospective study. Strahlenther Onkol 187:467-472
14. Stephenson AJ, Scardino PT, Kattan MW et al (2007) Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy. J Clin Oncol 25:2035-2041 (Pubitemid 46972788)
15. Stephenson AJ, Shariat SF, Zelefsky MJ (2004) Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy. JAMA 291:1325-1332 (Pubitemid 38541647)
16. Thompson IM, Jr., Tangen CM, Paradelo J et al (2006) Adjuvant radiotherapy for pathologically advanced prostate cancer: a randomized clinical trial. JAMA 296:2329-2335 (Pubitemid 44749360)
17. Thompson IM, Valicenti RK, Albertsen P et al (2013) Adjuvant and salvage radiotherapy after prostatectomy: AUA/ASTRO guideline. J Urol 190:441-449
18. Trabulsi EJ, Valicenti RK, Hanlon AL et al (2008) A multi-institutional matched-control analysis of adjuvant and salvage postoperative radiation therapy for pT3-4N0 prostate cancer. Urology 72:1298-1302
19. Trock BJ, Han M, Freedland SJ et al (2008) Prostate cancer-specific survival following salvage radiotherapy vs observation in men with biochemical recurrence after radical prostatectomy. JAMA 299:2760-2769 (Pubitemid 351846851)
20. Ward JF, Zincke H, Bergstralh EJ (2004) Prostate specific antigen doubling time subsequent to radical prostatectomy as a prognosticator of outcome following salvage radiotherapy. J Urol 172:2244-2248 (Pubitemid 39507500)
21. Wenz F, Martin T, Bohmer D et al (2010) The German S3 guideline prostate cancer: aspects for the radiation oncologist. Strahlenther Onkol 186:531-534
22. Wiegel T, Bottke D, Steiner U et al (2009) Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02/AUO AP 09/95. J Clin Oncol 27:2924-2930
23. Wiegel T, Lohm G, Bottke D et al (2009) Achieving an undetectable PSA after radiotherapy for biochemical progression after radical prostatectomy is an independent predictor of biochemical outcome-results of a retrospective study. Int J Radiat Oncol Biol Phys 73:1009-1016